[1] | |
[2] | |
[3] |
SHA R, XU Y, YUAN C, SHENG X, WU Z, PENG J, et al. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy[J/OL]. EBioMedicine, 2021, 71: 103560. DOI: 10.1016/j.ebiom.2021.103560
|
[4] | |
[5] |
闫莉. 隐丹参酮通过铁死亡抑制三阴性乳腺癌的机制研究[D]. 上海: 海军军医大学, 2021.
|
[6] | |
[7] |
ŽDRALEVI Ć M, VU Č ETI Ć M, DAHER B, MARCHIQ I, PARKS S K, POUYSSÉGUR J. Disrupting the 'Warburg effect' re-routes cancer cells to OXPHOS offering a vulnerability point via 'ferroptosis'-induced cell death[J]. Adv Biol Regul, 2018, 68: 55-63. DOI:10.1016/j.jbior.2017.12.002 |
[8] | |
[9] | |
[10] |
OU Y, WANG S J, LI D W, CHU B, GU W. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses[J/OL]. Proc Natl Acad Sci USA, 2016, 113: E6806-E6812. DOI: 10.1073/pnas.1607152113
|
[11] |
CHEN M S, WANG S F, HSU C Y, YIN P H, YEH T S, LEE H C, et al. CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2α-ATF4 pathway[J]. Oncotarget, 2017, 8: 114588-114602. DOI:10.18632/oncotarget.23055 |
[12] |
YUAN H, LI X M, ZHANG X Y, KANG R, TANG D L. CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation[J]. Biochem Biophys Res Commun, 2016, 478: 838-844. DOI:10.1016/j.bbrc.2016.08.034 |
[13] |
SHIMURA T, SHARMA P, SHARMA G G, BANWAIT J K, GOEL A. Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer[J/OL]. Sci Rep, 2021, 11: 7548. DOI: 10.1038/s41598-021-87283-y
|
[14] |
FANG Y, CHEN X, TAN Q, ZHOU H, XU J, GU Q. Inhibiting ferroptosis through disrupting the NCOA4-FTH1 interaction: a new mechanism of action[J]. ACS Cent Sci, 2021, 7: 980-989. DOI:10.1021/acscentsci.0c01592 |
[15] |
LIU X, YANG P, HAN L, ZHOU Q, QU Q, SHI X. The ncRNA-mediated overexpression of ferroptosis-related gene EMC2 correlates with poor prognosis and tumor immune infiltration in breast cancer[J/OL]. Front Oncol, 2021, 11: 777037. DOI: 10.3389/fonc.2021.777037
|
[16] |
TANG W Q, XU F S, ZHAO M, ZHANG S Q. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer[J/OL]. BMC Cancer, 2021, 21: 1160. DOI: 10.1186/s12885-021-08892-4
|
[17] |
XU C X, SUN S G, JOHNSON T, QI R, ZHANG S Y, ZHANG J, et al. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity[J/OL]. Cell Rep, 2021, 35: 109235. DOI: 10.1016/j.celrep.2021.109235
|
[18] |
DIXON S J, LEMBERG K M, LAMPRECHT M R, SKOUTA R, ZAITSEV E M, GLEASON C E, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149: 1060-1072. DOI:10.1016/j.cell.2012.03.042 |
[19] |
MONTES R, GURUCEAGA E, GONZÁLEZ-PORRAS J R, REVERTER J C, MARCO P, PINA E, et al. Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study[J]. Eur J Haematol, 2016, 97: 128-136. DOI:10.1111/ejh.12692 |
[20] | |
[21] |
ZEMLIN C, STUHLERT C, SCHLEICHER J T, WÖRMANN C, ALTMAYER L, LANG M, et al. Longitudinal assessment of physical activity, fitness, body composition, immunological biomarkers, and psychological parameters during the first year after diagnosis in women with non-metastatic breast cancer: the BEGYN study protocol[J/OL]. Front Oncol, 2021, 11: 762709. DOI: 10.3389/fonc.2021.762709
|
[22] |
JESSER E A, BRADY N J, HUGGINS D N, WITSCHEN P M, O CONNOR C H, SCHWERTFEGER K L. STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment[J/OL]. Breast Cancer Res, 2021, 23: 104. DOI: 10.1186/s13058-021-01481-0
|
[23] |
WANG X, HAN Y, PENG J M, HE J. CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer[J]. Aging, 2021, 13: 23810-23830. DOI:10.18632/aging.203654 |
[24] |
SAKAGUCHI A, HORIMOTO Y, ONAGI H, IKARASHI D, NAKAYAMA T, NAKATSURA T, et al. Plasma cell infiltration and treatment effect in breast cancer patients treated with neoadjuvant chemotherapy[J/OL]. Breast Cancer Res, 2021, 23: 99. DOI: 10.1186/s13058-021-01477-w
|
[25] |
WANG W M, GREEN M, CHOI J E, GIJÓN M, KENNEDY P D, JOHNSON J K, et al. CD8 + T cells regulate tumour ferroptosis during cancer immunotherapy[J]. Nature, 2019, 569: 270-274. DOI:10.1038/s41586-019-1170-y |